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The synthesis of propamidinef (4-4' diamidino-diphenoxypropane) was reported in 1942
by Ewins and his co-workers in the investigation of trypanocidal drugs (1). In 1943, the ther-
apeutic activity of propamidine as a topical antiseptic against Cram positive cocci
in chronic wound sepsis was demonstrated by Thrower and Valentine (2) and by other clini-
cal investigators (3, 4, 5). In 1945, Elson reported the in vitro sensitivity of Btastomyces
dermetitidis to propamidine (6). B. dermafitidis was completely inhibited by 3.75 micrograms
of propamidine per cc. of yeast extract agar. Because of the marked in vitro sensitivity of
B. dermatitidis and the absence of toxic symptoms in cases of wound sepsis treated with
topical application of propamidine, therapeutic trial in eases of cutaneous blastomycosis
seemed warranted.
It should be emphasized that, in spite of the lack of toxic symptoms reported, when pro-
pamidine is used in concentration of 0.1% as a local antiseptic, this drug and related aro-
matic diamidines produce general toxic effects when given systemically. After the intra-
venous injection of 2 mgm. of propamidine per kg. of body weight in the treatment of African
sleeping sickness, Lourie (7) noted the production of immediate and severe collapse which
was alarming but transitory. Late toxic effects have also have been reported with the
use of the aromatic diamidines. Delayed kidney and liver damage and dissociated anesthesia
of the trigeminal nerve have been particularly serious. An excellent review of these com-
pounds has been published recently by Sehoenbaeh and Greenspaa (5).
CASE HvST0RY
The patient is a 25-year-old white man who first noticed a skin lesion on the left shoulder
three years before admission. The lesion had begun as an erythematous papule which spread
radially until the skin overlying the entire left supraclavicular area, left upper anterior
chest, and left upper posterior chest was involved. Fifteen months before admission the
diagnosis of cutaneous blastomyeosis was made by one of the authors (M. S.). This diagnosis
was confirmed by culture and biopsy. Chest x-ray and blastomycin skin test were both nega-
tive, and therapy with Lugol's solution was instituted and maintained for five months with-
out significant improvement. Therapy was interrupted because of annoying epiphora, which
ceased with discontinuance of the drug. Eight months before admission, a course of x-ray
therapy was given and resulted in pronounced healing of the lateral and central portions of
the lesion. However, the medial, anterior, and posterior edges continued to advance, and
seven months after the last x-ray treatment the patient was admitted to the hospital for re-
evaluation and therapy.
In vitro sensitivity
B. dermatitidis was isolated from the advancing edge and then subcultured on
Sabouraud's dextrose agar. The subculture was then used for in vitro sensitivity determina-
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tions. Propamidine was incorporated into Sabouraud's dextrose agar in double dilutions
from 0.62 mgm./20 cc. of agar to 0.018 mg./20 cc. of agar. The organism was then streaked
on the plates, which were read after eighteen days at room temperature. Complete inhibition
was present at a concentration of 7.5 micrograms of propamidine per cc. of agar.
Clinical application
Before institution of therapy, chest x-ray and blastomycin skin test were repeated and
again found to be negative.
Propamidine was incorporated into 9% methyl cellulose gel to a concentration of 0.1%.
This concentration of propamidine is that recommended by Thrower and Valentine (2) for
treating wound sepsis, and, when applied locally in this concentration, no systemic toxicity
resulted. Dressings were done daily and in the following manner: the lesion was cleansed
with saline. A culture was taken by expressing pus from the elevated edge and streaking it
on a blood agar plate incubated at 37°C. and on Sabouraud's dextrose agar incubated at
room temperature. Propamidine gel was then applied to the surface of the lesion
with a sterile tongue depressor; vaseline gauze was placed over the gel, a sterile dry gauze
was applied, and the entire dressing was covered with a sterile towel. After nine days the
patient was discharged and followed as an outpatient. Six weeks after completion of the first
course of treatment, a second similar course was given.
RESULTS
Two cultures were done before beginning treatment. One culture, taken three weeks
before therapy, was positive for B. dermatitidis. The other culture, taken the day before
therapy, was negative for B. dermotitidis. Twenty cultures done during the first and second
courses of treatment were negative. However, a culture taken 2 weeks after completion of
the second course of therapy was positive for B. dermatitidis.
Clinically, the lesion has improved coincidently with the application of propamidine.
The elevated margin has flattened considerably, although complete healing has not oc-
curred. Epithelialization has advanced, especially over the more superficial areas. The
antero-medial edge, which is the point of maximum involvement, has improved, but at
present it shows less improvement than other areas, perhaps because the depth of tissue
involved renders topical application less efficacious. Tenderness has subsided over almost
the entire edge except for the afore-mentioned antero-medial area.
No evidence of systemic toxicity has been noted either by clinical observation or by per-
tinent laboratory procedures. However, the patient complained of pruritus locally and, nine
days after the onset of the first course of treatment, noted a burning sensation of the skin
surrounding the lesion. Irritation of the skin edges was reported by Thrower and Valentine
(2), and because of this irritation the maximum period recommended for a single course of
treatment was ten successive days.
SUMMARY
The treatment of a case of cutaneous blastomycosis with propamidine is reported. Al-
though complete healing has not occurred, a suggestively favorable clinical response has
been noted. It is realized that further treatment is necessary before any definitive statement
can be made. However, because of the prolonged follow-up required, the lack of other cases
available, and the suggestive clinical response, a preliminary report appeared worth while.
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